Registration Closing for the 2nd Annual Drug Discovery USA Congress 2015

Registration will shortly be closing for the 2nd Annual Drug Discovery USA Congress, taking place on the 29th and 30th of October 2015 in Boston. Our expert panel of speakers will address the current strategies for directed discovery, including the resurgence of phenotypic screening and comparing its utility with target based discovery. Our renowned speakers will explore novel peptide drug discovery, strategies for target selection and incorporating genomic technologies into discovery research. The Congress features an exciting stream dedicated to supporting innovation with informatics tools in which we will explore new data analysis and integration platforms, as well as ideas for efficient data exchange and pre-competitive collaboration.

 

Secure your place today to have access to the following streams:

- Target Based Discovery

- Screening & Assays: Enabling Technologies

- Discovery Chemistry & Drug Design

- Supporting Innovation: Translational Approaches & Informatics Tools

 

To review the full agenda, please visit: http://www.discoveryusa-congress.com/download-agenda-marketing/

 

Our dedicated research into the field ensures that we secure the very best quality speakers from top pharma companies and academic institutes to share their inspirational work with the conference attendees. We have ensured that every speaker has a unique story to bring to the audience and that they will present the latest, most exciting work – highlighting any pitfalls they have made along the way.

 

2015 speakers include:

-- Anabella Villalobos, Vice President, Neuroscience and Pain Medicinal Chemistry, Pfizer Inc

-- Frank K. Brown, AVP, Structural Chemistry, Merck & Co.

-- Omar Francone, VP, Head of Discovery Biology, Shire

-- Jean Cavallo, Associate Director, Molecular Pathology, Sanofi

-- Chris Burgey, Director, Medicinal Chemistry, Merck

-- Peter Dandliker, Director, Affinity Screening & Preclinical Pharmacology, Merck Research Laboratories

-- Hicham Alaoui, Director, Biochemical and Cellular Pharmacology, Genentech

-- Simon Bailey, Senior Director, Worldwide Medicinal Chemistry Oncology, Pfizer

 

To find out who else will be speaking, please visit: http://www.discoveryusa-congress.com/speakers

 

Attending this Congress will give you:

-- Full access to the 2 days of conference presentations

-- Lunch and Refreshments during the congress

-- Access to all networking activities

-- Access to exhibition area

-- Conference workbook and online access to conference materials, notes and presentations

 

Download the conference programme to find out more about this two day congress: http://www.discoveryusa-congress.com/download-agenda-marketing  

 

Reserve Your Place Today!

Registration continues with only a limited number of places available. If you’re looking to present a poster, we have limited spaces available on a strictly first come first served basis. For further information regarding our poster presentations, or to find out more about this or any of our upcoming events please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call us on +44(0)1865 248455.

 

You can also discover even more and discuss the latest methods in key issues in drug discovery and medicinal chemistry: LinkedIn: Drug Discovery & Development Network Group Twitter: https://twitter.com/DrugDiscoveryUS